Increased metastasis with loss of E2F2 in Myc-driven tumors.

Increased metastasis with loss of E2F2 in Myc-driven tumors.

Item
http://www.wikidata.org/entity/Q36545999
Targeting the RB-E2F pathway in breast cancerEpigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer.Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2.Stat3 accelerates Myc induced tumor formation while reducing growth rate in a mouse model of breast cancer.Mouse Models of Breast Cancer Share Amplification and Deletion Events with Human Breast Cancer.Clinical performance of E2Fs 1-3 in kidney clear cell renal cancer, evidence from bioinformatics analysis.miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.Transcription factor compensation during mammary gland development in E2F knockout mice.and Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients
P2860

Increased metastasis with loss of E2F2 in Myc-driven tumors.

Item
http://www.wikidata.org/entity/Q36545999
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Increased metastasis with loss of E2F2 in Myc-driven tumors.
@ast
Increased metastasis with loss of E2F2 in Myc-driven tumors.
@en
type
label
Increased metastasis with loss of E2F2 in Myc-driven tumors.
@ast
Increased metastasis with loss of E2F2 in Myc-driven tumors.
@en
prefLabel
Increased metastasis with loss of E2F2 in Myc-driven tumors.
@ast
Increased metastasis with loss of E2F2 in Myc-driven tumors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Increased metastasis with loss of E2F2 in Myc-driven tumors.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932